Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Class 2 Device Recall Flexima and Percuflex Drainage Catheter Family (Pigtail Style)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 


New Search Back to Search Results
  Class 2 Device Recall Flexima and Percuflex Drainage Catheter Family (Pigtail Style) see related information
Date Initiated by Firm March 18, 2009
Date Posted May 21, 2009
Recall Status1 Terminated 3 on February 23, 2012
Recall Number Z-1344-2009
Recall Event ID 51334
510(K)Number K900205¿  
Product Classification Diagnostic Biliary Catheter - Product Code FGE
Product Boston Scientific, Flexima¿ and Percuflex¿ Drainage Catheter Family (Pigtail Style)

UPN# DESCRIPTION
M0064102020 Percuflex All Purpose Drainage Catheters
wit Fader Tip and Locking Pigtail 8 Fr

M0064102030 Percuflex All Purpose Drainage Catheters with Fader
Tip and Locking Pigtail 10 Fr


Single Use Only, Sterilized with Ethylene Oxide Gas, Boston Scintific Corporation, One Boscton Scintific Place, Natick, MA 01760-1537, Made in USA 780 Brookside Drive, Spencer, IN 47460 1080.

Designed for percutaneous drainage of abscess fluid, the Biliary system and the urinary tract.
Code Information All codes   ¿   
Recalling Firm/
Manufacturer		 Boston Scientific Corporation
1 Scimed Pl
Maple Grove MN 55311-1565
For Additional Information Contact
800-272-3737
Manufacturer Reason
for Recall		 Boston Scientific Corporation is initiating an urgent Field Correction related to its Flexima¿ and Percuflex¿ Drainage Catheter Family (Pigtail Style). During the attempted removal of the device, sutures were separated from the catheter and remained in the patient.
FDA Determined
Cause 2		 Labeling False and Misleading
Action Consignees were sent a Boston Scientific " Urgent Medical Device Field Correction Notification" letter dated March 18, 2009. The letter was addressed to "The Hospital Field Action Contact". The letter described the problem, product affected and the revised catheter removal instructions. They also requested the return of the Acknowledgement Form.
Quantity in Commerce 586,276 US; 276,013 OUS total for all products
Distribution Worldwide Distribution -- USA including DC, Puerto Rico and Guam and countries of United Arab Emirates Austria, Bosnia and Herzegovina, Bahrain, Switzerland, Germany, Egypt, Spain, Finland, France, Great Britain, Ireland, Italy, Kuwait, Netherland, Pakistan, Portugal, Saudi Arabia, Sweden, Slovak Republic, Tunisia, Turkey, South Africa, Netherlands, Costa Rica, Japan, Argentina, Australia, Brazil, Canada, Chile, China, Columbia, Ecuador, El Salvador, Guatemala, Honduras, Hong Kong, Macau, Malaysia, Mexico New Zealand, Panama, Peru, Philippines, Puerto Rico, Singapore, South Korea, Sri Lanka, Taiwan, Thailand, Uruguay, and Venezuela.
Total Product Life Cycle TPLC Device Report
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls.
2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.
3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
-
-